Fullerton, CA 的 乳癌 臨床試驗
9 項針對 乳癌 的研究正在 Fullerton（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
招募中3 期
- Providence Medical Foundation, Fullerton
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
招募中3 期
- Providence Medical Foundation-Oncology ( Site 0020), Fullerton
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
招募中3 期
- Providence Medical Foundation ( Site 0080), Fullerton
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
招募中1/2 期
- Providence Medical Foundation, Fullerton
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
招募中3 期
- Providence St. Jude Medical Center - Virginia K. Crosson Cancer Center, Fullerton
E-Mindfulness Approaches for Living After Breast Cancer
招募中3 期
- UCI Health - Yorba Linda, Yorba Linda · 距離 7 英里
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
招募中3 期
- Providence Medical Foundation, Fullerton
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
招募中
- St Jude Heritage Medical Group, Fullerton
Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
招募中2 期
- St. Joseph Heritage Healthcare, Fullerton
其他城市的 乳癌 試驗
- New York City, NY136 項研究
- Houston, TX126 項研究
- Boston, MA112 項研究
- Nashville, TN81 項研究
- Los Angeles, CA73 項研究
- Edison, NJ68 項研究
- St. Louis, MO64 項研究
- Queens, NY64 項研究
- Durham, NC64 項研究
- Chicago, IL59 項研究
- Philadelphia, PA56 項研究
- Dallas, TX55 項研究
Fullerton 的其他研究
- 非小細胞肺癌13 項研究
- 卵巢癌6 項研究
- 紅斑性狼瘡5 項研究
- 癌症（所有類型）5 項研究
- 肺癌4 項研究
- 胰臟癌4 項研究
- 胃癌3 項研究
- 食道癌3 項研究
- 黑色素瘤3 項研究
- 頭頸部鱗狀細胞癌3 項研究
- 精神分裂症3 項研究
- 大腸直腸癌3 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。